



Increased intracellular survival of Salmonella Typhimurium ST313 in HIV-1-
infected primary human macrophages is not associated with Salmonella  
hijacking the HIV compartment  
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Non-Typhoidal Salmonella (NTS) causes a severe invasive syndrome (iNTS disease) 
described in HIV-positive adults. The impact of HIV-1 on Salmonella pathogenesis and 
the molecular basis for the differences between these bacteria and classical diarrhoeal 
S. Typhimurium remains unclear.  
Results 
Here we show that iNTS-associated S. Typhimurium Sequence Type 313 (ST313) 
bacteria show greater intracellular survival in primary human macrophages, compared 
with a ‘classical’ diarrhoeal S. Typhimurium ST19 isolate. The increased intracellular 
survival phenotype of ST313 is more pronounced in HIV-infected macrophages. We 
explored the possibility that the bacteria take advantage of the HIV-associated viral-
containing compartments created in human macrophages that have low pH. Confocal 
fluorescence microscopy and Focused Ion Beam-Scanning Electron Microscopy (FIB-
SEM) tomography showed that Salmonella did not co-localise extensively with HIV-
positive compartments.  
Conclusion 
The capacity of ST313 bacteria to survive better than ST19 bacteria within primary 
human macrophages is enhanced in cells pre-infected with HIV-1. Our results indicate 
that the ST313 bacteria do not directly benefit from the niche created by the virus in 
HIV-1 infected macrophages, and that they might take advantage from a more globally 
modified host cell.  
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Significance 
A better understanding of the interplay between HIV-1 and Salmonella is important not 






Macrophages are phagocytic cells that populate all tissues and organs of the body 
where they play important roles in pathogen clearance, removal of cell debris and 
matrix degradation. Many of these functions rely upon to their capacity to perform 
phagocytosis, a mechanism of internalisation of large particulate material that relies on 
the ligation of surface receptors (Niedergang, 2016; Niedergang and Grinstein, 2018).  
As with other cells that express the receptor, CD4, and co-receptors, CXCR4 and 
CCR5, macrophages can be infected by the human immunodeficiency virus type 1 
(HIV-1). Macrophages, however, resist the cytopathic effect of the virus and represent 
one of the viral reservoirs, even in treated patients (Rodrigues et al., 2017). For 
instance, urethral macrophages were recently reported to constitute a principal site of 
replication competent HIV-1 reservoir (Ganor et al., 2019).  
We and others have previously demonstrated that HIV-1-infected macrophages have 
impaired phagocytic capacity against a variety of phagocytic targets, coupled with 
defective phagolysosome maturation and clearance capacity. These defective 
phagocytic capacities enable bacteria and other opportunistic pathogens to better 
survive intracellularly (Biggs et al., 1995; Crowe et al., 1994; Dumas et al., 2015; 
Kedzierska et al., 2003; Torre et al., 2002). Many intracellular pathogens have been 
associated with opportunistic infections of HIV-infected hosts, including 
Mycobacterium tuberculosis, Toxoplasma gondii, Candida albicans, Aspergillus 
fumigatus, etc. In 1990, non-typhoidal salmonellae (NTS) were identified as HIV-
associated pathogens in sub-Saharan African adults (Gilks et al., 1990). Later, invasive 
non-typhoidal Salmonella disease (iNTS) became recognized as a common and 
recurrent illness among susceptible African children and HIV-infected adults (Gordon 
et al., 2001), and was responsible for 66,000 deaths in Africa in 2017 (Collaborators, 
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2019). This systemic disease differs from the self-limiting diarrheal disease that has 
classically been associated with S. Typhimurium in immunocompetent individuals 
(Gilchrist and MacLennan, 2019).  
The S. Typhimurium serovar causes two-thirds of iNTS in sub-Saharan Africa, and 
phylogenetic analysis has revealed that the bacteria represent a distinct pathovariant 
that is multidrug resistant and belongs to a specific multi-locus sequence type, ST313 
(Canals et al., 2019; Kingsley et al., 2009; Okoro et al., 2012; Van Puyvelde et al., 
2019). Recent studies have addressed the abilities of the ST313 bacteria to 
disseminate systemically, as well as their capacity to survive intracellularly in various 
experimental models, including macrophages (Carden et al., 2015; Herrero-Fresno et 
al., 2014; Lacharme-Lora et al., 2019; Ramachandran et al., 2015; Singletary et al., 
2016). However, the impact of a HIV-pre-infection on these cells remains to be 
investigated (Le-Bury and Niedergang, 2018).  
The HIV-1 lifecycle in macrophages differs to that in CD4+ T cells and model cell lines, 
where viral assembly and budding takes place at the plasma membrane. In 
macrophages, the virus buds and is stored in a compartment called Virus-Containing 
Compartment (VCC) (Tan and Sattentau, 2013). This compartment has unique 
properties that distinguishes it from other multivesicular bodies: the VCC lacks 
lysosomal markers, has a non-acidic pH, and is connected to the plasma membrane 
(Rodrigues et al., 2017). S. Typhimurium also survives in a specific compartment, the 
Salmonella-Containing Vacuole (SCV), that resists fusion with lysosomal contents 
(Holden, 2002; Malik-Kale et al., 2011). 
Here, we test the hypothesis that in HIV-1 infected macrophages, intracellular S. 
Typhimurium could take advantage of the neutral HIV-1-associated compartment to 
achieve increased survival. The intracellular fate of both pathogens, HIV-1 and S. 
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Typhimurium, were specifically analysed, using confocal fluorescent microscopy and 
Focused Ion Beam-Scanning Electron Microscopy (FIB-SEM) (Kizilyaprak et al., 2019; 
Weiner and Enninga, 2019). These experiments revealed that S. Typhimurium and in 
particular ST313 survive inside macrophages without directly hijacking the viral 
compartment in human macrophages. 
 
RESULTS  
Enhanced survival of ST313 bacteria in HIV-infected human primary 
macrophages  
To characterize the impact of HIV-1 infection on bacterial survival of invasive S. 
Typhimurium, we used an infection model involving primary human monocyte-derived 
macrophages that were pre-infected with HIV-1 for 8 days. In this paper, we refer to 
the un-infected macrophages as HIV-1-, and to the HIV-1-infected macrophages as 
HIV-1+. The two types of macrophages were then infected with ST313 D23580, or a 
representative non-invasive isolate ST19 4/74 (Figure 1A). A gentamicin protection 
assay was performed and results were expressed as Colony Forming Units per mL 
(CFU/mL) (Figure 1B) or fold-change intracellular survival of ST313 versus ST19 
bacteria (Figure 1C). In the experimental conditions used, 10-50% of macrophages 
were productively infected with HIV-1, and all cells were co-infected with bacteria 
(Dumas et al., 2015). Initially, similar levels of ST313 and ST19 were internalized into 
HIV-1- and HIV-1+ primary macrophages (Figure 1B “entry”), as reported previously in 
primary mouse bone marrow-derived macrophages (BMDM) (Carden et al., 2015), but 
not seen in murine cell lines such as J774 (Ramachandran et al., 2015). At later stages 
of infection, ST313 invasive bacteria showed a clear trend towards a higher (2 to 3 
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times) level of intracellular survival inside human macrophages, compared with 
reference ST19 bacteria, as in (Ramachandran et al., 2015). Interestingly, this was 
observed in both HIV-1- and HIV-1+ macrophages (Figure 1B-C, “20-24 h”). In addition, 
despite the relatively low rate of HIV-infection, at 24 h post-infection, there was a trend 
for increased survival of ST313 versus ST19 in HIV-1+ macrophages (3 times more), 
compared to HIV-1- cells (2 times more).  
Taken together, these data suggest that the ability of ST313 bacteria to survive better 
than ST19 bacteria within primary human macrophages is enhanced in cells pre-
infected with HIV-1.  
 
Salmonella Typhimurium and HIV-1 are located in different compartments in 
primary human macrophages  
The improved survival of ST313 versus ST19 in HIV-infected macrophages raised the 
possibility that there was a direct connection between the SCV and the non-acidic 
VCC. To determine if bacteria can ‘hijack’ the VCC, the localisation of HIV-1 and the 
ST19 reference bacteria or the ST313 iNTS bacteria was determined on fixed co-
infected primary macrophages that were fluorescently-labelled with antibodies 
targeting the p24 capsid protein of HIV and the Salmonella O-antigen. Co-localisation 
of the virus and the two types of Salmonella were determined using Pearson correlation 
coefficients (PCC) (Figure 2A-C). The resulting PCC values were < 0.3, indicating a 
low association between HIV and both Salmonella pathovariants (Figure 2C). The 
values were above zero, so transient contacts between the SCV and VCC 
compartments cannot be excluded.  
 
To search for transient connections between the VCC and the bacteria, we analyzed 
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the dynamic behaviour of the two types of pathogens in living macrophages co-infected 
with HIV-1NLR4.3 Gag-iGFP and DsRed-expressing ST313 (SSS18 (pMR98)) (Figure 2E). 
As expected (Bakowski et al., 2008), after internalisation, the bacteria gradually moved 
towards the cell centre, close to the VCC. However, the fluorescent signals from 
bacteria and virus originated from different focal planes (3D representation in Figure 
2E). The PCC calculated for three different cells remain low during the 6 h experiment 
(PCC <0.2), confirming that the bacterial and viral compartments were not closely 
associated in the co-infected cells over this time period (Figure 2D).  
 
Three-dimensional ultrastructural analysis of Salmonella Typhimurium- and HIV-
1-containing compartments in human primary macrophages using FIB-SEM 
To visualize the pathogen compartments, an electron microscopy analysis was 
performed. For this, human macrophages were plated on a gridded dish, co-infected 
with HIV-1 for 8 days and DsRed-expressing ST313 for 6 h post-invasion of bacteria. 
After fixation, cells were observed with confocal fluorescence microscopy (Figure 3A) 
and some were selected for FIB-SEM analysis. The images from one co-infected 
macrophage revealed the location of the VCC and bacterial compartments (Figure 3B, 
original dataset stack can be found on line at https://imagerie.cochin.inserm.fr as 
described in the Methods). The 3D reconstruction of the image stacks highlights the 
compartments’ contours (Figure 3C and Supp Figure movie 1 on line). The cell 
appeared to have two nuclei (in blue). Interestingly, the plasma membrane showed 
extensive ruffles. One striking feature of the reconstructed 3D view is that the 
compartments containing the bacteria were not tight around the microorganisms but 
rather show large membrane ruffles and extensions (Figure 3C membranes in purple, 
and bacteria in red, in ii and iii where the membranes are transparent). These are 
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reminiscent of the SIFs (Salmonella-induced filaments)(Knuff and Finlay, 2017), but 
extended SCV membranes decorated with late-endocytic markers were not detected 
in macrophages by fluorescence microscopy (not shown). No direct membrane 
continuity was observed between the viral compartment, (Figure 3C green) and the 
bacterial compartments (Figure 3C purple), although transient connections between 
the compartments cannot be excluded. These results demonstrate that the SCV is not 
extensively connected with the VCC in co-infected macrophages at the time points 
analysed. We conclude that the enhanced ST313 bacterial survival and replication 
observed in HIV-1-infected macrophages does not reflect direct hijacking of the VCC 




Here we analysed the intracellular fate of S. Typhimurium ST313 in HIV-1- and HIV-1+ 
primary human macrophages. We found that S. Typhimurium ST313 D23580 showed 
a trend of increased survival and replication in human monocyte-derived 
macrophages, compared with ST19 4/74. This is consistent with a previous report that 
involved intracellular infection experiments with S. Typhimurium ST313 in the THP-1 
human monocytic cell line, in PBMCs from healthy human donors and in murine 
peritoneal macrophages (Ramachandran et al., 2015). We have now discovered that 
ST313 shows even higher levels of survival than ST19 in HIV-infected macrophages 
(Figure 1C “20-24h”). 
In this study, the temporal and spatial distribution of cellular structures containing two 
different pathogens, HIV-1 and S. Typhimurium in primary human macrophages, were 
analysed using both live fluorescence imaging and FIB/SEM. The combination of 
dynamic fluorescence imaging and the high resolution FIB/SEM approach allowed us 
to obtain a unique perspective on the two compartments. Although the VCC is located 
in a perinuclear region (Rodrigues et al., 2017), close to where the bacterial 
compartment traffics after bacterial invasion of the macrophage, the two fluorescence 
signals did not show significant co-localisation (Figure 2).  
Fluorescence microscopy, however, was limited by the ability to detect the 
fluorescently-labelled microorganisms, namely the GFP-labelled viral capsids and the 
DsRed-expressing bacteria. Further, fluorescence microscopy yielded no information 
on the membranous compartments surrounding the two pathogens. FIB/SEM 
tomography is a volume EM technique allowing the acquisition of large-volume 
tomograms using a focused ion beam/scanning EM, well adapted to the study of 
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intracellular pathogens (Kizilyaprak et al., 2019; Weiner and Enninga, 2019). While 
HIV-1 positive structures engaged in virological synapses with T lymphocytes have 
been imaged with FIB/SEM (Do et al., 2014; Wang et al., 2017), the compartment had 
not previously been observed in macrophages with this approach. What was striking 
from the obtained dataset, is the extensive network of membrane extensions and folds 
that emanate from the viral compartment as well as from the bacterial vacuole. 
However, despite these membrane extensions, the compartments were not in direct 
contact at the time points analysed. Therefore, the invasive bacteria did not seem to 
take direct advantage of the intracellular niche created by the HIV virus.  
However, transient connections between the bacterial- and viral- compartments cannot 
be excluded. Only one full dataset could be analysed in this study and it is possible 
that connections could occur at a later time point. In future, potential transient 
connections could be investigated by loading the viral compartment with a luminal cell 
tracer before the addition of bacteria labelled with another luminal tracer. Other 
membranous markers could also be used to visualize the VCC and the SCV (Knuff and 
Finlay, 2017; Rodrigues et al., 2017).  
Considering the volume of membrane, and thus lipids, needed for the production of 
enveloped viruses in infected cells, hijacking of intracellular trafficking is crucial for the 
production of new virions. It is likely that the infection of macrophages with HIV-1 leads 
to profound modifications of intracellular trafficking (Rodrigues et al., 2017). This was 
observed previously with the sorting protein EHD3 recruited on the viral compartment, 
and impaired phagolysosome biogenesis and bacterial clearance in HIV-positive 
macrophages (Dumas et al., 2015). Such changes in intracellular trafficking could 
therefore benefit any secondary bacterial infection (Le-Bury and Niedergang, 2018). In 
addition, the major modifications in the gene expression programmes of HIV-1 infected 
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macrophages might account for the higher sensitivity of HIV-1-infected cells to 
subsequent bacterial challenge and defective clearance activity, which is the focus of 
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Figure legends  
Figure 1 – Increased intracellular replication and survival of ST313 in both HIV-
1- and HIV-1+ primary human macrophages, compared with ST19 bacteria  (A) 
Schematic representation of the experimental design. Primary human macrophages 
were infected with HIV-1ADAWT or not for 8 days and then co-infected with S. 
Typhimurium ST19 4/74 or ST313 D23580 for 20 min. At this point, designated t=0, 
cells were washed with media containing gentamicin. At different time points post-
infection, cells were lysed or fixed and prepared for plating or imaging. (B) Numbers of 
intracellular bacteria were assessed by viable count at 20-30 min, 4-6 h or 20-24 h. 
Each point shows the mean value from three technical replicates for one donor and 
the points between HIV-1- and HIV-1+ macrophages from individual donors are 
connected. The bar shows the mean value for all donors (n≥3) Two-tailed p-values by 
paired t-test are shown. (C) Results are expressed as a ratio of the number (CFU) of 
intracellular ST313, compared with ST19 bacteria. The mean ± SEM at least of three 
independent experiments on different donors is presented. 
Figure 2 – Localization of S. Typhimurium and HIV-1 following co-infection in 
primary human macrophages. (A-C) Primary human macrophages were co-infected 
with HIV-1ADAWT and  with S. Typhimurium ST19 4/74 (A, upper panel) or ST313 iNTS 
D23580 (A, lower panel). Cells were fixed, permeabilized, and labelled with anti-p24 
(to localize HIV) followed by AlexaFluor-488-labeled anti-goat IgG (A, green, second 
column) and anti-Salmonella O-antigen, followed by Cy3-labeled anti-rabbit IgG (A, 
red, third column). (A) Maximum Z-projections of 6h after infection were represented. 
Scale bar, 10 µm. (B) Scatter plot of red (Salmonella-Cy5) and green (HIV-GFP) pixel 
intensities of cells in (A) infected with ST19 (upper graph) or with ST313 (lower graph). 
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(C) Co-localization of HIV p24-positive structures and S. Typhimurium ST313 or ST19 
in co-infected cells using the Pearson correlation coefficient (PCC). Each point 
represents the PCC within one cell, and bars show the mean value for 3 donors. (D-E) 
Primary human macrophages were co-infected with HIV-1NLR4.3iGag-GFP and with 
DsRed-expressing ST313 D23580. (D) The co-localization between the virus (GFP+) 
and the bacteria (DsRed+) was determined by PCC, using ICY software. Means of 3 
cells from 3 independent donors are represented. (E) To visualize S. Typhimurium and 
HIV, maximum Z-projections (ImageJ) (upper panels), and 3D reconstructions (ICY) 
(lower panels) were made. Scale bar, 10 µm.  
 
Figure 3 – Following co-infection, HIV-1 and S. Typhimurium localise to two 
different compartments in human primary macrophages analysed by FIB-SEM. 
Primary human macrophages were infected with HIV-1NLR4.3iGag-GFP for 8 days, and 
then co-infected with DsRed-expressing ST313 for 6h. (A) Z-stacks of images at 0.3 
μm increments were acquired with spinning disk confocal inverted microscope. 
Maximum Z-projections are represented after image treatment performed using 
custom-made ImageJ routines. Scale bars, 50 µm (left panel) and 20 µm (right panel). 
(B) Representative scanning electron micrograph of a FIB-SEM image stack with a 
horizontal field of view corresponding to 30 µm (i). In this image, bacteria (ii) and HIV 
compartments (iii) were identified and manually segmented using IMOD. (C) The final 
volume is segmented in order to colour the nuclei in blue, the plasma membrane in 
gold, two different bacteria in red, surrounded by their compartment in purple, and HIV 
particles in white in the membranous viral compartment (green). (ii and iii) correspond 
to a zoom in the volume of interest to visualise the compartments in more detail.  
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MATERIALS & METHODS 
Cell culture of human Monocytes-Derived Macrophages (hMDMs) – Blood of 
healthy donors was used (Etablissement Français du Sang, Ile de France, Site Saint 
Vincent-de-Paul, Trinité or Saint-Antoine) with the appropriate ethics prior approval as 
stated in the EFS/ Inserm agreement #15/EFS/012 and #18/EFS/030, ensuring that all 
donors gave a written informed consent, and providing anonymized samples. Primary 
human Peripheral Blood Mononuclear Cells (PBMCs) were isolated by density gradient 
sedimentation in Ficoll (GE Healthcare). Then monocytes were selected by adhesion 
to dishes for 2 h at 37°C in Fetal Calf Serum [FCS]-free medium (RPMI 1640 medium 
supplemented with 100 Units/mL penicillin and 100 g/mL streptomycin (Gibco), and 2 
mM L-glutamine (Gibco)). And they are differentiated into macrophages for at least 11 
days in complete medium (previous medium supplemented with 10% Fetal Calf 
Serum) and 10 ng/mL recombinant human macrophage colony-stimulating factor (rhM-
CSF; R&D systems) (Dumas et al., 2015; Mazzolini et al., 2010). 
Viral production and human macrophage infection – Proviral infectious clones of 
the macrophage-tropic virus isolate ADA (HIV-1ADAWT) have been described 
previously (Mazzolini et al., 2010). The NLR4.3 HIV-1Gag-iGFP carrying an R5-tropic 
envelope with the V3-loop V92th014.12 was a kind gift of Michael Schindler 
(Koppensteiner et al., 2012). Stocks of viral particles were obtained by transfection of 
HEK293T cells (Human Embryonic Kidney 293, ATCC®CRL-1573™, 2x106) with 6 µg 
of the corresponding proviral DNA, using FuGENE® 6 Transfection Reagent as 
recommended by the manufacturer (Promega). Supernatants of the transfected cells 
were collected after 48 h, filtered, and stored at -80°C. Viral titers were assessed by 
infection of the indicator cells, HeLa TZM-bl (bearing the β-galactosidase gene under 
the control of HIV-1 LTR, National Institutes of Health-NIH reagent program), with serial 
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dilutions of the stock, followed by a β-galactosidase coloration of the cells and counting 
of blue cells. 
At 11 days of macrophage differentiation, HIV-1 virus (MOI 0.2) was added to hMDMs. 
Excess virus was removed after 2 days and cells were kept for 6 days before S. 
Typhimurium infection or functional assays.  
Bacterial strains growth conditions and bacterial infection – S. Typhimurium 
ST313 isolate D23580 and ST19 isolate 4/74 were described previously (Kingsley et 
al., 2009; Kroger et al., 2013; Okoro et al., 2012). S.  Typhimurium SSS18, a 
chloramphenicol and ampicillin-sensitive derivative of S. Typhimurium ST313 isolate 
D23580(kind gift from Robert Kingsley, Quadram Institute, Norwich, UK), was used to 
introduce thethe  pMR98-DsRed replicative plasmid expressing DsRed protein by 
electroporation (Niedergang et al., 2000). Bacteria were grown overnight at 37°C under 
aerobic conditions with shaking in Lysogeny Broth (LB) with 50 µg/mL Ampicillin to 
maintain selection for pMR98-DsRed. Then, S. Typhimurium was subcultured (starting 
with dilution of 1/30) for 2 h until late-logarithmic phase. MOI was determined for 
bacterial suspensions by measuring absorbance at 600nm, and estimating that 109 
bacteria/mL give an A600 of 1. The bacterial suspension was diluted in RPMI 1640 
medium supplemented with 2 mM L-glutamine to infect cells and the inoculum dose 
was calculated by plating serial dilutions onto LB agar plates. 
Gentamicin assays – In 6-well plates, HIV-1ADAWT-infected or not infected hMDMs 
(5.105 to 1.106 cells/well) were infected at a MOI of 30 with 1 mL of bacterial suspension 
inoculum. Plates were then centrifuged for 2 min at 500 g to synchronize the infection 
and the kinetics was started by incubating the plates at 37°C in 5% CO2. 
After 20 min of incubation at 37°C, hMDMs were gently washed twice with sterile 
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PBS1X without CaCl2/MgCl2 (Gibco), and incubated in complete RPMI medium 
supplemented with 50 µg/mL of gentamic, and this was designated  t=0. At the 
indicated times post-infection, cells were washed twice with PBS1X and lysed with 
0.5% Triton X-100 in PBS1X. The number of viable intracellular bacteria present at 
each time point was determined by plating serial dilutions on LB agar plates. 
Imaging fixed cells – In 24-well plates, HIV-1ADAWT-infected hMDMs or not (2.105 
cells/well) were infected at a MOI of 30 with 0.5 mL of bacterial suspension inoculum. 
Plates were then centrifuged for 2 min at 500 g to synchronize the infection and the 
kinetics was started by incubating the plates at 37°C in 5% CO2. After the invasion 
step at 20 min, hMDMs cells were fixed or were gently washed 2 times with sterile 
PBS1X (Gibco), and then incubated in complete RPMI medium supplemented with 50 
µg/mL of gentamicin for 6 h before fixation. Cells were fixed with 4% formaldehyde 
(PFA – Sigma-Aldrich) with 4% sucrose for 15 min, then remaining aldehyde groups 
were inactivated with NH4Cl 50 mM in PBS1X for 7 min at room temperature (RT), and 
cells were washed with PBS1X. Cells were blocked and permeabilized with 0.05% 
saponin, 2% FCS in PBS1X (PBS/FCS/Sap) before labelling. S. Typhimurium and HIV-
1 were labelled with rabbit anti-Salmonella LPS antibodies (Difco) and goat anti-p24 
HIV-1 antibodies (AbD Serotec 4999-9007) in PBS/FCS/Sap for 45 min respectively, 
followed by 30 min for secondary antibodies in PBS/FCS/Sap: donkey Alexa Fluor647-
labeled F(ab’)2 anti-rabbit IgG and donkey Alexa Fluor 488-labeled F(ab’)2 anti-goat 
IgG (Jackson ImmunoResearch). Nuclei and S. Typhimurium were labelled with 4',6-
diamidino-2-phenylindole (DAPI ; Sigma) at 0.3 µg/mL in PBS1X for 5 min. Mounting 
medium was Fluoromount-G (eBioscience). Image acquisition was performed on an 
inverted wide-field microscope (Leica DMI600) with a HCX PL APO 100X/1.4 numeric-
aperture (NA) oil phase contrast (PH) objective (Nikon) and ORCA Flash4.0 
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(Hamamatsu) camera. Z-series of images were taken at 0.2 μm increments and 
deconvolution was performed with Huygens software (Scientific Volume Imaging) 
when indicated. Analysis was performed using custom-made ImageJ (National 
Institutes of Health) routines and co-localization was estimated using JACoP plugin of 
ImageJ software to calculate the Pearson correlation coefficient (PCC). 
 
Live cell imaging – hMDMs differentiated for 11 days were detached using PBS/EDTA 
2 mM, and seeded on gridded MatTeck Glass Bottom Dishes (P35G-2-14-CGRD) at 
1.106 cells/well. HIV-1NLR4.3 Gag-iGFP-infected hMDMs were infected at a MOI of 30 with 
1 mL of bacterial suspension inoculum (iNTS SSS18 carrying replicative DsRed 
plasmid). Plates were then centrifuged for 2 min at 500 g to synchronize the infection 
and the kinetics was started by incubating the plates at 37°C in 5% CO2. 
After the invasion step, hMDMs were gently washed twice with sterile PBS1X without 
CaCl2/MgCl2, and then incubated in complete RPMI medium supplemented with 50 
µg/mL of gentamicin for 6 h for acquisition. Samples were observed with a spinning 
disk confocal (CSU-X1M1; Yokogawa) inverted microscope (DMI6000; Leica) 
equipped with a CoolSnap HQ2 camera (Photometrics) and a heated chamber at 37°C 
with 5% CO2 in a BSL3 laboratory. GFP, DsRed and PH images were acquired every 
5 min using HCX PLAN APO 63X/1.4 NA oil PH objective on MetaMorph 7.5.5 software 
(Molecular Devices). Z-series of images were taken at 0.3 μm increments. Image 
treatments were performed using custom-made ImageJ routines, and calculation of 
Pearson coefficient and 3D reconstructions were performed using ICY (Pasteur 
Institute) software. 
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For FIB-SEM analysis, cells were washed with 0.2 M HEPES and then fixed with 2.5% 
glutaraldehyde in 0.2 M HEPES for 2 h at RT. 
Focused Ion Beam (FIB)-Scanning Electron Microscope (SEM) tomography – To 
identify co-infected cells, HIV-1-GFP and Salmonella-DsRed were observed with a 100 
X, 1.4 NA, PH DIC objective with a spinning disk confocal (Yokogawa CSU-X1M1) 
inverted microscope (Leica DMI6000) equipped with a CoolSnap HQ2 camera 
(Photometrics) and a heated chamber with CO2 in a BSL3 laboratory. Acquisition was 
performed with MetaMorph 7.5.5 (Molecular Devices). 
Cells were then post-fixed in a chemical mix containing 2.5% glutaraldehyde (EMS # 
16300), 1% osmium tetroxide (EMS # 19150) and 1.5% Potassium 
hexacyanoferrate(II) trihydrate (Sigma # 60280) in phosphate buffer (0.1 M, pH7.4) 
(Sigma # P3619) for 2 h at RT. Cells were then washed three times for 5 min in distilled 
water and dehydrated in graded series of ethanol, (30% for 5 min, 50% for 5 min, en-
bloc stained in 2% uranyl acetate (EMS # 22400) in 50% ethanol for 1 h, 70% ethanol 
for 5 min, 80% for 5 min, 2 times 95% for 10 min, and three times in pure ethanol for 6 
min). This was followed by infiltration in epoxy resin (43.5% epoxy medium, 36.5% 
DDSA, 18% MNA, 1.5% DMP30) (Sigma # 45359) using a drop of fresh epoxy resin 
on the monolayer overnight and finally polymerized for 48 h at 60°C. The epoxy blocks 
containing the monolayer were glued on aluminium SEM specimen stubs with EPO-
TEK H20S conductive resin (EMS # 12672-20S) as described previously (Kizilyaprak 
et al., 2015; Kizilyaprak et al., 2019). The stub was mounted in the FIB-SEM (Helios 
Nanolab 650, FEI Company) using the 45° aluminium SEM-mount (EMS # 75230).  
The preparation regime of the block in the FIB-SEM microscope is depicted in 
Kizilyaprak et al. (Kizilyaprak et al., 2015). Cell of interest (COI) was localized using 
the gridded reference system on the epoxy block. The FIB-SEM tomography of the 
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COI was performed with the FEI Slice and View softwareTM. The stage was tilted to 7° 
in order to have the block-surface normal to the ion beam. The milling was done at 30 
kV acceleration voltage, 790 pA current and 1 µs dwell time using a slice thickness 
corresponding to 10 nm. For image acquisition the stage was tilted to 45° to have the 
freshly milled face normal to the electron beam. The cross-section images were 
acquired by detecting backscattered electrons with the through-the-lens detector 
(BSE-TLD) in immersion mode using an electron beam of 2 kV, 800 pA and 20 µs of 
dwell time with a frame of 4096x3536 corresponding to a pixel size of 7.3 nm. Image 
stack was aligned by cross-correlation and manually segmented using the IMOD 
software package (University of Colorado, Boulder, Colorado, USA). A stack with 
reduced number of sections (1 out of 5) is available on line 
https://imagerie.cochin.inserm.fr/openData.php?id=4740776 for visualization or 
download after registration with a valid email address to get a password.  
 



